Hongliang Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongliang Yao has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Kuijie Liu
Department of General Surgery, the Second Xiangya Hospital, Central South University, Changsha, China
5 shared publications Beibei Cui
Department of General Surgery, the Second Xiangya Hospital, Central South University, Changsha, China
3 shared publications- Beibei Cui
Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
3 shared publications - Jun He
Department of General Surgery, the Second Xiangya Hospital, Central South University, Changsha, China
3 shared publications Kuijie Liu
Department of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, China
3 shared publicationsSanlin Lei
Department of Gastroenterology, the Second Xiangya Hospital, Central South University, Changsha, China
3 shared publications
Latest Publications
- 13 May 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 489
Research hotspots and trends of robotic hernia repair: a bibliometric analysis (2005–2025)
Robotic hernia repair (RHR) has evolved into a technological evolution, offering enhanced visualization and precision compared to traditional laparoscopy. This bibliometric analysis evaluated 588 articles (2005–2025) retrieved from the Web of Science Core Collection. Global trends, contributors, collaborations, and emerging hotspots were identified using the R package “bibliometrix”. Research volume in RHR has increased significantly over the past two decades, primarily driven by publications in Surgical Endoscopy, Hernia, and the Journal of Robotic Surgery. The USA, Japan, and Germany were the most cited countries, while Tufts University, University of Southern Denmark, and Odense University Hospital were the most productive affiliations. Omar Yusef Kudsi, Fahri Gokcal, and Naseem Bou-Ayash were the most prolific authors. Furthermore, the RIVAL randomized controlled trial by Prabhu et al. (JAMA Surg, 155 (5) 380–387. https://doi.org/10.1001/jamasurg.2020.0034) was the most cited manuscript. Keyword analysis demonstrates a clinical evolution from initial procedural feasibility and learning curves toward complex abdominal wall reconstructions, notably including the enhanced-view totally extraperitoneal and the transversus abdominis release. To fully harness the benefits of RHR, future efforts must extend beyond technological innovation to prioritize widespread clinical adoption and establish strong inter-institutional networks.
- 13 May 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 489
Research hotspots and trends of robotic hernia repair: a bibliometric analysis (2005–2025)
Robotic hernia repair (RHR) has evolved into a technological evolution, offering enhanced visualization and precision compared to traditional laparoscopy. This bibliometric analysis evaluated 588 articles (2005–2025) retrieved from the Web of Science Core Collection. Global trends, contributors, collaborations, and emerging hotspots were identified using the R package “bibliometrix”. Research volume in RHR has increased significantly over the past two decades, primarily driven by publications in Surgical Endoscopy, Hernia, and the Journal of Robotic Surgery. The USA, Japan, and Germany were the most cited countries, while Tufts University, University of Southern Denmark, and Odense University Hospital were the most productive affiliations. Omar Yusef Kudsi, Fahri Gokcal, and Naseem Bou-Ayash were the most prolific authors. Furthermore, the RIVAL randomized controlled trial by Prabhu et al. (JAMA Surg, 155 (5) 380–387. https://doi.org/10.1001/jamasurg.2020.0034) was the most cited manuscript. Keyword analysis demonstrates a clinical evolution from initial procedural feasibility and learning curves toward complex abdominal wall reconstructions, notably including the enhanced-view totally extraperitoneal and the transversus abdominis release. To fully harness the benefits of RHR, future efforts must extend beyond technological innovation to prioritize widespread clinical adoption and establish strong inter-institutional networks.
- 13 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1786-1796
Effects of Metabolic Bariatric Surgery on Weight Loss and Diabetes Remission Over 10 Years: A Network Meta-Analysis of Randomized Controlled Trials
- 13 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1786-1796
Effects of Metabolic Bariatric Surgery on Weight Loss and Diabetes Remission Over 10 Years: A Network Meta-Analysis of Randomized Controlled Trials
- 16 October 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (1) , 67-75
Risk of suicide after metabolic bariatric surgery: a meta-analysis of matched cohort studies and population-based studies
- 16 October 2024
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 21 (1) , 67-75
Risk of suicide after metabolic bariatric surgery: a meta-analysis of matched cohort studies and population-based studies
- 2 December 2023
- Published by Springer Nature
- p. 903-912
Experience Sharing on New Ideas and New Techniques in NOSES
- 2 December 2023
- Published by Springer Nature
- p. 903-912
Experience Sharing on New Ideas and New Techniques in NOSES
- Open Access
- 25 August 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-18
The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma
Colon adenocarcinoma (COAD) is a serious public health problem, the third most common cancer and the second most deadly cancer in the world. About 9.4% of cancer-related deaths in 2020 were due to COAD. Anoikis is a specialized form of programmed cell death that plays an important role in tumor invasion and metastasis. The presence of anti-anoikis factors is associated with tumor aggressiveness and drug resistance. Various bioinformatic methods, such as differential expression analysis, and functional annotation analysis, machine learning, were used in this study. RNA-sequencing and clinical data from COAD patients were obtained from the Gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Construction of a prognostic nomogram for predicting overall survival (OS) using multivariate analysis and Lasso-Cox regression. Immunohistochemistry (IHC) was our method of validating the expression of seven genes that are linked to anoikis in COAD. We identified seven anoikis-related genes as predictors of COAD survival and prognosis, and confirmed their accuracy in predicting colon adenocarcinoma prognosis by KM survival curves and ROC curves. A seven-gene risk score consisting of NAT1, CDC25C, ATP2A3, MMP3, EEF1A2, PBK, and TIMP1 showed strong prognostic value. Meanwhile, we made a nomogram to predict the survival rate of COAD patients. The immune infiltration assay showed T cells. CD4 memory. Rest and macrophages. M0 has a higher proportion in COAD, and 11 genes related to tumor immunity are important. GDSC2-based drug susceptibility analysis showed that 6 out of 198 drugs were significant in COAD. Anoikis-related genes have potential value in predicting the prognosis of COAD and provide clues for developing new therapeutic strategies for COAD. Immune infiltration and drug susceptibility results provide important clues for finding new personalized treatment options for COAD. These findings also suggest possible mechanisms that may affect prognosis. These results are the starting point for planning individualized treatment and managing patient outcomes.
- 25 August 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-18
Open AccessThe anoikis-related gene signature predicts survival accurately in colon adenocarcinoma
Colon adenocarcinoma (COAD) is a serious public health problem, the third most common cancer and the second most deadly cancer in the world. About 9.4% of cancer-related deaths in 2020 were due to COAD. Anoikis is a specialized form of programmed cell death that plays an important role in tumor invasion and metastasis. The presence of anti-anoikis factors is associated with tumor aggressiveness and drug resistance. Various bioinformatic methods, such as differential expression analysis, and functional annotation analysis, machine learning, were used in this study. RNA-sequencing and clinical data from COAD patients were obtained from the Gene expression omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases. Construction of a prognostic nomogram for predicting overall survival (OS) using multivariate analysis and Lasso-Cox regression. Immunohistochemistry (IHC) was our method of validating the expression of seven genes that are linked to anoikis in COAD. We identified seven anoikis-related genes as predictors of COAD survival and prognosis, and confirmed their accuracy in predicting colon adenocarcinoma prognosis by KM survival curves and ROC curves. A seven-gene risk score consisting of NAT1, CDC25C, ATP2A3, MMP3, EEF1A2, PBK, and TIMP1 showed strong prognostic value. Meanwhile, we made a nomogram to predict the survival rate of COAD patients. The immune infiltration assay showed T cells. CD4 memory. Rest and macrophages. M0 has a higher proportion in COAD, and 11 genes related to tumor immunity are important. GDSC2-based drug susceptibility analysis showed that 6 out of 198 drugs were significant in COAD. Anoikis-related genes have potential value in predicting the prognosis of COAD and provide clues for developing new therapeutic strategies for COAD. Immune infiltration and drug susceptibility results provide important clues for finding new personalized treatment options for COAD. These findings also suggest possible mechanisms that may affect prognosis. These results are the starting point for planning individualized treatment and managing patient outcomes.
- Open Access
- 17 March 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1153751
Robotic natural orifice specimen extraction surgery versus conventional robotic resection for patients with colorectal neoplasms
Background: Laparoscopic natural orifice specimen extraction surgery (NOSES) has been widely used in colorectal neoplasms. However, only a few studies have focused on robotic NOSES. This study compared the short-term clinical outcomes and long-term survival outcomes between robotic NOSES and conventional robotic resection (CRR) groups.Methods: From March 2016 to October 2018, a consecutive of 143 patients who underwent robotic sigmoid and rectal resection at the Department of Gastrointestinal Surgery, The Second Xiangya Hospital, Central South University, were considered for inclusion in this study. Propensity-score matching (PSM) was conducted to account for differences in the baseline characteristics. After PSM, 39 patients were included in the robotic NOSES group, and 39 patients in the CRR group. The baseline characteristics between the two groups were all balanced and comparable.Results: Patients in the NOSES group experienced less intraoperative blood loss (p=0.001), lower requirements for additional analgesia (p=0.020), shorter time to first flatus (p=0.010), and a shorter time to first liquid diet (p=0.003) than the CRR group. The 3-year overall survival rates (NOSES: 92.3% vs. CRR: 89.7% p=1.000) and 3-year disease-free survival rates (NOSES: 82.1% vs. CRR: 84.6% p=0.761) between the two groups were comparable.Conclusion: Robotic natural orifice specimen extraction surgery is a safe and feasible surgery for patients with colorectal neoplasms. Robotic NOSES is associated with better short-term clinical outcomes and similar long-term survival outcomes to conventional robotic resection.
- 17 March 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1153751
Open AccessRobotic natural orifice specimen extraction surgery versus conventional robotic resection for patients with colorectal neoplasms
Background: Laparoscopic natural orifice specimen extraction surgery (NOSES) has been widely used in colorectal neoplasms. However, only a few studies have focused on robotic NOSES. This study compared the short-term clinical outcomes and long-term survival outcomes between robotic NOSES and conventional robotic resection (CRR) groups.Methods: From March 2016 to October 2018, a consecutive of 143 patients who underwent robotic sigmoid and rectal resection at the Department of Gastrointestinal Surgery, The Second Xiangya Hospital, Central South University, were considered for inclusion in this study. Propensity-score matching (PSM) was conducted to account for differences in the baseline characteristics. After PSM, 39 patients were included in the robotic NOSES group, and 39 patients in the CRR group. The baseline characteristics between the two groups were all balanced and comparable.Results: Patients in the NOSES group experienced less intraoperative blood loss (p=0.001), lower requirements for additional analgesia (p=0.020), shorter time to first flatus (p=0.010), and a shorter time to first liquid diet (p=0.003) than the CRR group. The 3-year overall survival rates (NOSES: 92.3% vs. CRR: 89.7% p=1.000) and 3-year disease-free survival rates (NOSES: 82.1% vs. CRR: 84.6% p=0.761) between the two groups were comparable.Conclusion: Robotic natural orifice specimen extraction surgery is a safe and feasible surgery for patients with colorectal neoplasms. Robotic NOSES is associated with better short-term clinical outcomes and similar long-term survival outcomes to conventional robotic resection.
- Open Access
- 6 January 2023
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 1049666
Benign duodenocolic fistula: A case report and review of the literature
Duodenocolic fistula is a rare upper gastrointestinal fistula that can be benign or malignant. However, benign duodenocolic fistulas are particularly rare. Duodenocolic fistulas are often a complication of advanced colon cancer. The most common cause of benign fistulas is perforation of the duodenal ulcer. We report a case of a benign duodenocolic fistula in a patient who presented with abdominal pain, diarrhea, and weight loss. Gastroscopy and an upper gastrointestinal study confirmed the presence of the fistula. Surgery was performed, and the pathological examination demonstrated that the fistula originated from a duodenal ulcer.
- 6 January 2023
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 1049666
Open AccessBenign duodenocolic fistula: A case report and review of the literature
Duodenocolic fistula is a rare upper gastrointestinal fistula that can be benign or malignant. However, benign duodenocolic fistulas are particularly rare. Duodenocolic fistulas are often a complication of advanced colon cancer. The most common cause of benign fistulas is perforation of the duodenal ulcer. We report a case of a benign duodenocolic fistula in a patient who presented with abdominal pain, diarrhea, and weight loss. Gastroscopy and an upper gastrointestinal study confirmed the presence of the fistula. Surgery was performed, and the pathological examination demonstrated that the fistula originated from a duodenal ulcer.
- 6 November 2022
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 17 (3) , 905-914
A propensity score matching study of totally robotic right hemicolectomy versus robot-assisted right hemicolectomy
To compare and analyze the differences in safety, feasibility and short-term efficacy between robot-assisted right hemicolectomy (RARH) and totally robotic right hemicolectomy (TRRH). We collected the information of 184 patients who underwent right hemicolectomy in the Second Xiangya Hospital of Central South University from July 2016 to December 2021. We matched 148 patients (74 with robot-assisted right hemicolectomy and 74 with totally robotic right hemicolectomy) to conduct a retrospective analysis of their clinical outcomes. The incision lengths were 5.14 ± 0.60 cm in the RARH group and 4.74 ± 0.55 cm in the TRRH (p < 0.001). The blood losses were 86.28 ± 52.57 mL in the RARH group and 69.19 ± 44.78 mL in the TRRH (p = 0.035). The operative times were 197.50 min (171.25–242.25) in the RARH group and 160.00 min (145.00–188.75) in the TRRH (p < 0.001). The postoperative hospital stays were 11.18 ± 4.32 days in the RARH group and 9.53 ± 4.42 days in the TRRH (p = 0.023). The NRS pain scores were 3.05 ± 0.23 in the RARH group and 2.96 ± 0.26 in the TRRH (p = 0.019). The abdominal drainage extraction times were 7.54 ± 1.44 days in the RARH group and 7.00 ± 1.25 days in the TRRH (p = 0.016). Postoperative complications in the RARH group are fewer than TRRH (p = 0.033). TRRH is safe and feasible. Compared with RARHs, the TRRHs resulted in shorter incision lengths, operative times, intraoperative blood losses, postoperative hospital stays, first flatus times, first liquid diet times, and drainage tube removal times, and they improved NRS pain scores and postoperative complication frequencies.
- 6 November 2022
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 17 (3) , 905-914
A propensity score matching study of totally robotic right hemicolectomy versus robot-assisted right hemicolectomy
To compare and analyze the differences in safety, feasibility and short-term efficacy between robot-assisted right hemicolectomy (RARH) and totally robotic right hemicolectomy (TRRH). We collected the information of 184 patients who underwent right hemicolectomy in the Second Xiangya Hospital of Central South University from July 2016 to December 2021. We matched 148 patients (74 with robot-assisted right hemicolectomy and 74 with totally robotic right hemicolectomy) to conduct a retrospective analysis of their clinical outcomes. The incision lengths were 5.14 ± 0.60 cm in the RARH group and 4.74 ± 0.55 cm in the TRRH (p < 0.001). The blood losses were 86.28 ± 52.57 mL in the RARH group and 69.19 ± 44.78 mL in the TRRH (p = 0.035). The operative times were 197.50 min (171.25–242.25) in the RARH group and 160.00 min (145.00–188.75) in the TRRH (p < 0.001). The postoperative hospital stays were 11.18 ± 4.32 days in the RARH group and 9.53 ± 4.42 days in the TRRH (p = 0.023). The NRS pain scores were 3.05 ± 0.23 in the RARH group and 2.96 ± 0.26 in the TRRH (p = 0.019). The abdominal drainage extraction times were 7.54 ± 1.44 days in the RARH group and 7.00 ± 1.25 days in the TRRH (p = 0.016). Postoperative complications in the RARH group are fewer than TRRH (p = 0.033). TRRH is safe and feasible. Compared with RARHs, the TRRHs resulted in shorter incision lengths, operative times, intraoperative blood losses, postoperative hospital stays, first flatus times, first liquid diet times, and drainage tube removal times, and they improved NRS pain scores and postoperative complication frequencies.
- Open Access
- 28 July 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
A Novel Mechanism of the c-Myc/NEAT1 Axis Mediating Colorectal Cancer Cell Response to Photodynamic Therapy Treatment
Photodynamic therapy (PDT) is considered a potential treatment regimen for colorectal cancer cases (CRC). p53 signaling and the miR-124/iASPP axis play an essential role in the PDT resistance of CRC cells. PDT treatment downregulated NEAT1 expression in p53wt HCT116 and RKO cells. In these two cell lines, NEAT1 silencing enhanced the suppressive effects of PDT on cell viability and apoptosis. Within the subcutaneously implanted tumor model, NEAT1 silencing enhanced PDT-induced suppression on tumor growth. Regarding p53-deleted HCT116 cells, PDT only moderately affected cell proliferation but induced downregulation of NEAT1. NEAT1 directly targeted miR-124, acting as a ceRNA, competing with iASPP for miR-124 binding, and counteracting miR-124–mediated repression on iASPP under PDT treatment. NEAT1 silencing was enhanced, whereas miR-124 inhibition attenuated PDT effects on CRC cells; miR-124 inhibition significantly reversed the roles of NEAT1 silencing in PDT-treated CRC cells. miR-124 negatively correlated with NEAT1 and iASPP, respectively, whereas NEAT1 and iASPP positively correlated with each other. PDT downregulated c-Myc in CRC cells, and c-Myc activated the transcription of NEAT1 through the targeting of its promoter region. Within p53mut SW480 cells, PDT failed to alter cell viability and apoptosis but still downregulated c-Myc, NEAT1, and iASPP and upregulated miR-124. In p53 mutant high-abundant CRC tissues, c-Myc and NEAT1 were up-regulated, and miR-124 was downregulated. In c-Myc high-abundant CRC tissues, NEAT1 and iASPP were up-regulated, and miR-124 was downregulated. The critical role of the c-Myc/NEAT1 axis in mediating CRC response to PDT treatment via the miR-124/iASPP/p53 feedback loop was conclusively demonstrated.
- 28 July 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Open AccessA Novel Mechanism of the c-Myc/NEAT1 Axis Mediating Colorectal Cancer Cell Response to Photodynamic Therapy Treatment
Photodynamic therapy (PDT) is considered a potential treatment regimen for colorectal cancer cases (CRC). p53 signaling and the miR-124/iASPP axis play an essential role in the PDT resistance of CRC cells. PDT treatment downregulated NEAT1 expression in p53wt HCT116 and RKO cells. In these two cell lines, NEAT1 silencing enhanced the suppressive effects of PDT on cell viability and apoptosis. Within the subcutaneously implanted tumor model, NEAT1 silencing enhanced PDT-induced suppression on tumor growth. Regarding p53-deleted HCT116 cells, PDT only moderately affected cell proliferation but induced downregulation of NEAT1. NEAT1 directly targeted miR-124, acting as a ceRNA, competing with iASPP for miR-124 binding, and counteracting miR-124–mediated repression on iASPP under PDT treatment. NEAT1 silencing was enhanced, whereas miR-124 inhibition attenuated PDT effects on CRC cells; miR-124 inhibition significantly reversed the roles of NEAT1 silencing in PDT-treated CRC cells. miR-124 negatively correlated with NEAT1 and iASPP, respectively, whereas NEAT1 and iASPP positively correlated with each other. PDT downregulated c-Myc in CRC cells, and c-Myc activated the transcription of NEAT1 through the targeting of its promoter region. Within p53mut SW480 cells, PDT failed to alter cell viability and apoptosis but still downregulated c-Myc, NEAT1, and iASPP and upregulated miR-124. In p53 mutant high-abundant CRC tissues, c-Myc and NEAT1 were up-regulated, and miR-124 was downregulated. In c-Myc high-abundant CRC tissues, NEAT1 and iASPP were up-regulated, and miR-124 was downregulated. The critical role of the c-Myc/NEAT1 axis in mediating CRC response to PDT treatment via the miR-124/iASPP/p53 feedback loop was conclusively demonstrated.